Low risk of in-transit metastasis in patients with cutaneous melanoma undergoing sentinal lymph node biopsy

Journal of Clinical Oncology

Volumn 23, Issue 21, 2005, Pages 4588-4590

  Pawlik, Timothy M ^a   Ross, Merrick I ^a   Thompson, John F ^a   Eggermont, Alexander M M ^a   Gershenwald, Jeffrey E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; HUMAN; LYMPH FLOW; MELANOMA; METASTASIS; NOTE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; ARTICLE; LYMPH NODE METASTASIS; PATHOLOGY; SKIN TUMOR; TUMOR RECURRENCE;

HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 23044503344     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.12.245     Document Type: Note

References (25)

1. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
2. Ross MI, Reintgen D, Balch CM: Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 9:219-223, 1993
3. Pawlik TM, Ross MI, Gershenwald JE: Lymphatic mapping in the molecular era. Ann Surg Oncol 11:362-374, 2004
4. Gershenwald JE, Thompson W, Mansfield PF, et al: Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:976-983, 1999
5. Thomas JM, Clark MA: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 30:686-691, 2004
6. Thomas JM, Clark MA: Sentinel lymph node biopsy: Not yet standard of care for melanoma. BMJ 329:170, 2004
7. Thomas JM, Clark MA: Are there guidance issues relating to sentinel node biopsy for melanoma in the UK? Br J Plast Surg 57:689-690, 2004
8. Estourgie SH, Nieweg OE, Kroon BB: The sentinel node procedure in patients with melanoma. Eur J Surg Oncol 30:713-714, 2004
9. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al: Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 10:681-688, 2003
10. Estourgie SH, Nieweg OE, Kroon BB: High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 91:1370-1371, 2004
11. Borgstem PJ, Meijer S, van Diest PJ: Are locoregional cutaneous metastases in melanoma predictable? Ann Surg Oncol 6:315-321, 1999
12. Cascinelli N, Bufalino R, Marolda R, et al: Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 12:175-180, 1986
13. Wong JH, Cagle LA, Kopald KH, et al: Natural history and selective management of in transit melanoma. J Surg Oncol 44:146-150, 1990
14. Leon P, Daly JM, Synnestvedt M, et al: The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 126:1461-1468, 1991
15. Day CL Jr, Harnst TJ, Gorstein F, et al: Malignant melanoma: Prognostic significance of " microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg 194:108-112, 1981
16. Calabro A, Singletary SE, Balch CM: Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 124: 1051-1055, 1989
17. Zogakis TG, Bartlett DL, Libutti SK, et al: Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma. Ann Surg Oncol 8:771-778, 2001
18. Attie JN, Khafif RA: Clinical aspects of melanotic tumors, in Melanotic Tumors: Biology, Pathology and Clinical Features. Springfield, IL, Charles C. Thomas, 1964, pp 147-150
19. Karakousis CP, Choe KJ, Holyoke ED: Biologic behavior and treatment of intransit metastasis of melanoma. Surg Gynecol Obstet 150:29-32, 1980
20. Pawlik T, Ross M, Johnson M, et al: Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol (in press)
21. van Poll D, Thompson JF, McKinnon JG, et al: A sentinel node biopsy procedure does not increase the incidence of in-transit recurrence in patients with primary melanoma. Ann Surg Oncol (in press)
22. Kretschmer L, Beckmann I, Thorns KM, et al: Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas. Eur J Cancer 41:531-538, 2005
23. Morton DL, Cochran AJ: Presidential Address. Presented at the 4th Annual International Sentinel Node Congress, Los Angeles, CA, December 3-6, 2004
24. Cascinelli N, Morabito A, Santinami M, et al: Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial-WHO Melanoma Programme. Lancet 351:793-796, 1998
25. Kretschmer L, Hilgers R, Mohrle M, et al: Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer 40:212-218, 2004